Bank of New York Mellon
BDTX icon

Bank of New York Mellon’s Black Diamond Therapeutics BDTX Stock Holding History

Bank of New York Mellon’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$590K Buy
318,763
+129,615
+69% +$317K ﹤0.01% 3665
2026
Q1 		$403K Sell
189,148
-25,523
-12% -$60.7K ﹤0.01% 3700
2025
Q4 		$522K Buy
214,671
+88,999
+71% +$315K ﹤0.01% 3587
2025
Q3 		$476K Hold
125,672
– – ﹤0.01% 3624
2025
Q2 		$312K Sell
125,672
-81,155
-39% -$156K ﹤0.01% 3777
2025
Q1 		$321K Sell
206,827
-247
-0.1% -$518 ﹤0.01% 3671
2024
Q4 		$443K Buy
207,074
+65,341
+46% +$187K ﹤0.01% 3585
2024
Q3 		$617K Buy
141,733
+32,774
+30% +$178K ﹤0.01% 3397
2024
Q2 		$508K Buy
+108,959
New +$585K ﹤0.01% 3580
2023
Q2 		– Sell
-18,191
Closed -$34.4K – 4392
2023
Q1 		$34.4K Hold
18,191
– – ﹤0.01% 4251
2022
Q4 		$32.7K Sell
18,191
-74
-0.4% -$133 ﹤0.01% 4294
2022
Q3 		$31K Hold
18,265
– – ﹤0.01% 4389
2022
Q2 		$45K Sell
18,265
-69,293
-79% -$161K ﹤0.01% 4362
2022
Q1 		$243K Sell
87,558
-1,993
-2% -$7.28K ﹤0.01% 4137
2021
Q4 		$477K Sell
89,551
-9,833
-10% -$68.7K ﹤0.01% 3836
2021
Q3 		$841K Buy
99,384
+17,889
+22% +$177K ﹤0.01% 3494
2021
Q2 		$993K Buy
81,495
+20,021
+33% +$396K ﹤0.01% 3428
2021
Q1 		$1.49M Sell
61,474
-2,065
-3% -$55.7K ﹤0.01% 3096
2020
Q4 		$2.04M Buy
63,539
+4,934
+8% +$162K ﹤0.01% 2834
2020
Q3 		$1.77M Buy
58,605
+12,076
+26% +$368K ﹤0.01% 2742
2020
Q2 		$1.96M Buy
46,529
+16,082
+53% +$592K ﹤0.01% 2695
2020
Q1 		$760K Buy
+30,447
New +$927K ﹤0.01% 3154

Other funds holding BDTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Bank of New York Mellon's BDTX Position: Q2 2026 in Review

Bank of New York Mellon increased its Black Diamond Therapeutics (BDTX) stake by 69% in Q2 2026, buying an estimated $317K and bringing the position to 318,763 shares worth $590K. The position accounts for ﹤0.01% of the portfolio, ranked #3665.

Bank of New York Mellon first reported a position in BDTX in Q1 2020 and has held it in 22 quarters since. The position peaked at $2.04M in Q4 2020. 43 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

  • Bank of New York Mellon held 318,763 shares of Black Diamond Therapeutics worth $590K as of Q2 2026.
  • Bank of New York Mellon bought 129,615 Black Diamond Therapeutics shares in Q2 2026, an estimated $317K.
  • Black Diamond Therapeutics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3665 holding.
  • Bank of New York Mellon first reported a position in Black Diamond Therapeutics in Q1 2020 and has held it in 22 quarters since.
  • Bank of New York Mellon's Black Diamond Therapeutics position peaked at $2.04M in Q4 2020.
  • 43 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.